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REPORT
Focal CA3 hippocampal subfield atrophy
following LGI1 VGKC-complex antibody limbic
encephalitis
Thomas D. Miller,1,2 Trevor T.-J. Chong,3 Anne M. Aimola Davies,4,5 Tammy W.C. Ng,6
Michael R. Johnson,7 Sarosh R. Irani,1 Angela Vincent,1 Masud Husain,1,4 Saiju Jacob,8
Paul Maddison,9 Christopher Kennard,1 Penny A. Gowland10 and Clive R. Rosenthal1
Magnetic resonance imaging has linked chronic voltage-gated potassium channel (VGKC) complex antibody-mediated limbic
encephalitis with generalized hippocampal atrophy. However, autoantibodies bind to speciﬁc rodent hippocampal subﬁelds.
Here, human hippocampal subﬁeld (subiculum, cornu ammonis 1-3, and dentate gyrus) targets of immunomodulation-treated
LGI1 VGKC-complex antibody-mediated limbic encephalitis were investigated using in vivo ultra-high resolution
(0.39  0.39  1.0 mm3) 7.0T magnetic resonance imaging [n = 18 patients, 17 patients (94%) positive for LGI1 antibody and
one patient negative for LGI1/CASPR2 but positive for VGKC-complex antibodies, mean age: 64.0  2.55 years, median 4 years
post-limbic encephalitis onset; n = 18 controls]. First, hippocampal subﬁeld quantitative morphometry indicated signiﬁcant volume
loss conﬁned to bilateral CA3 [F(1,34) = 16.87, P 5 0.0001], despite hyperintense signal evident in 5 of 18 patients on presen-
tation. Second, early and later intervention (53 versus 43 months from symptom onset) were associated with CA3 atrophy.
Third, whole-brain voxel-by-voxel morphometry revealed no signiﬁcant grey matter loss. Fourth, CA3 subﬁeld atrophy was
associated with severe episodic but not semantic amnesia for postmorbid autobiographical events that was predicted by variability
in CA3 volume. The results raise important questions about the links with histopathology, the impact of the observed focal
atrophy on other CA3-mediated reconstructive and episodic mechanisms, and the role of potential antibody-mediated pathogenicity
as part of the pathophysiology cascade in humans.
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Introduction
Autoantibodies to two main antigenic components of volt-
age-gated potassium channel (VGKC)-complex—LGI1 and
CASPR2 proteins—are preferentially expressed in two
rodent hippocampal subﬁelds, cornu ammonis (CA)3 and
CA1 (Irani et al., 2010). Encephalitis in patients positive
for VGKC-complex, LGI1, or CASPR2 antibodies can pre-
sent with inﬂammatory changes of the medial temporal
lobe on acute MRI (Kotsenas et al., 2014), and whole-hip-
pocampal atrophy in the convalescent and chronic phases
(Irani et al., 2013; Malter et al., 2014). Neuropsychological
assessment, following immunomodulation therapy, reveals
substantial variability in outcome (Chan et al., 2007; Frisch
et al., 2013; Bettcher et al., 2014; Butler et al., 2014;
Malter et al., 2014), unlike the more severe deﬁcits often
observed in progressive medial temporal lobe diseases such
as Alzheimer’s disease (Wolk et al., 2011).
Evidence of in vivo pathology restricted to one or two
human hippocampal subﬁelds is uncommon. Focal lesions
in CA1 have been associated with transient epileptic am-
nesia (Bartsch et al., 2011), whereas in a recent case study
involving hypoxic-ischaemic brain injury, the lesion proﬁle
was conﬁned to the bilateral dentate gyrus and a portion of
CA3 (Baker et al., 2016). In both cases, the subﬁeld lesions
were associated with episodic amnesia (Bartsch et al., 2011;
Baker et al., 2016). To our knowledge, pathology conﬁned
to human CA3 has not been previously reported in vivo,
but evidence from molecular imaging in a rodent model
and functional MRI in humans indicates CA3 activity is
associated with episodic retrieval (Bonnici et al., 2013;
Lux et al., 2016).
In the current study, the human hippocampal subﬁeld
targets of immunomodulation-treated chronic LGI1
VGKC-complex antibody-mediated limbic encephalitis
were investigated for the ﬁrst time using ultra-high spatial
resolution MRI conducted at 7.0T (17/18 patients were
positive for LGI1 antibody and one patient was VGKC-
complex-antibody positive and negative for LGI1 and
CASPR2 antibodies). Whole-hippocampal images
(390 mm2 in-plane spatial resolution) were acquired to con-
duct detailed 3D in vivo hippocampal subﬁeld quantitative
manual morphometry of ﬁve subﬁelds (CA1–3, dentate
gyrus, subiculum). By comparison, previous reports have
conducted automated volumetry of mesiotemporal struc-
tures, based on whole-brain images acquired at 43.0T
and lower spatial resolution 51.0 mm3 (Irani et al.,
2013; Finke et al., 2017), and either collapse across indi-
vidual subﬁelds or report total hippocampal volume. In
addition, whole-brain, voxel-by-voxel morphometry was
conducted on high-resolution (600 mm isotropic) T1-
weighted images to test for grey matter reductions across
the rest of the brain. Finally, to the extent that CA3 inter-
acts with CA1 and the dentate gyrus to support episodic
memory (Baker et al., 2016), we tested the hypothesis that
CA3 and/or CA1 atrophy would be linked with selective
deﬁcits in the retrieval of experiential, ﬁrst person compo-




Eighteen patients (mean age: 64.0  2.55 years; range: 24–71;
15 male), all with a formal clinical diagnosis of VGKC-com-
plex antibody-mediated limbic encephalitis, participated [mean
titre = 2270pmol/l; interquartile range = 648–3922; standard
deviation (SD) = 1836]. Clinical records were retrospectively
interrogated for time-to-treatment from ﬁrst symptom, ﬁrst-
line treatments (Supplementary material), and evidence of
medial temporal lobe involvement on presentation. Seventeen
of the patients were LGI1 positive and one was positive for
VGKC-complex antibodies and negative for LGI1 and
CASPR2. Patients were recruited if they were 412-months
post-symptom onset (median time from ﬁrst symptom-to-treat-
ment = 3 months) and considered clinically stable. Eighteen
healthy age-matched controls were recruited (64.61.94
years; range: 22–76; 11 male), and had no history of cognitive,
psychiatric, or neurological illness. The local research ethics
committee approved the protocol. Informed written consent
was obtained from all participants for all procedures.
MRI
Image acquisition
All participants were scanned to acquire three MRI sequences
on a 7.0 T whole body MRI scanner (Achieva, Philips
Healthcare): (i) a rapid whole-head sagittal T1-weighted loca-
lizer image to verify head position; (ii) a T2-weighted 3D fast
spin-echo coronal sequence with the refocusing pulse adjusted
to optimize contrast covering both hippocampi (voxel size,
0.390.391.0 mm3); and (iii) a 3D whole-brain T1-
weighted phase sensitive inversion recovery sequence providing
inherent receiver bias ﬁeld correction in the image reconstruc-
tion and using a tailored radiofrequency pulse for
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magnetization inversion at ultrahigh ﬁeld (isotropic voxel size,
0.6 mm3). Scan parameters are reported in the Supplementary
material.
Hippocampal subfield segmentation
Quantitative morphometry of CA1–3, dentate gyrus, and the
subiculum was conducted on left and right hippocampal sub-
ﬁelds, deriving 10 volumes (mm3), and guided by a previously
described 7.0T manual segmentation protocol (Fig. 1) (Wisse
et al., 2012), modiﬁed so that CA2 and the boundary between
CA1 and the subiculum were additionally delineated on each
slice. Manual segmentation was performed on the 3D fast-spin
echo images using the freehand spline drawing and manual
segmentation tools in ITK-SNAP 3.2 (http://www.itksnap.
org). To evaluate intra-rater reliability, all hippocampi were
fully re-segmented after a month had elapsed. A subset of pa-
tient and control scans also underwent manual segmentation
by a second rater to generate inter-rater reliability indices.
Both raters were blinded to the identity of all scans.
Whole-brain voxel-by-voxel morphometry
An automated voxel-based morphometry analysis, imple-
mented within SPM12 software and executed in Matlab
R2013a, was conducted on the T1-weighted whole-brain
images to test for grey matter differences between the patients
and controls (Supplementary material). The T1-weighted
images were also used to derive total intracranial volumes to
compensate for interindividual variability in head size.
Behaviour
Neuropsychological assessment and postmorbid
autobiographical memory
To obtain a detailed neuropsychological proﬁle, the patients
underwent a comprehensive assessment using standardized
neuropsychological tests. Separately, the ability of patients
(n = 16) and controls (n = 16) to recollect postmorbid experi-
ential, episodic, and semantic event details was also assessed
on an objective, parametric, text-based procedure—the auto-
biographical interview (Levine et al., 2002)—that has been
administered to study autobiographical memory in health
and in disease (Addis et al., 2007). See Supplementary material
for further details.
Statistical analyses
Intra- and inter-rater reliability of manual segmentation was
assessed using the Dice similarity indices (DSIs) of geometric
overlap for the ﬁve subﬁelds and derived using Convert3D
(www.itksnap.org). In addition, intra-class correlation coefﬁ-
cients (ICCs) were used to calculate the agreement between
twice-repeated manual segmentations of all ﬁve subﬁelds as a
function of side (left, right) and twice-repeated scoring of data
acquired on the autobiographical interview. A two-way mixed-
model design was used to test the degree of absolute
agreement.
Hippocampal subﬁeld volumes were examined using a
mixed-model omnibus ANOVA and planned between-group
comparisons. Contrasts involving unequal subgroups were
conducted by means of non-parametric median test and
Kruskal-Wallis test and post hoc tests. Contrasts following
from these parametric and non-parametric tests were assessed
with the alpha criterion corrected for multiple comparisons
using the Bonferroni-Holm procedure. Volumetric data were
assessed against other variables with robust multiple linear
regression conducted using Huber’s method of correction for
outliers. Statistics were computed using IBM SPSS Version




The ICCs for each subﬁeld indicate a high-to-excellent con-
sistency for all hippocampal subﬁelds in patients (median:
0.965) and controls (median: 0.961). Intra-rater DSIs for
each subﬁeld revealed high-reliability for patients and con-
trols (median patient and control DSIs generalized across
all subﬁelds: 0.76 and 0.79, respectively). Inter-rater DSIs
of two independent raters for patients and controls were
also reliable (median patient and control DSIs generalized
across all subﬁelds: 0.75 and 0.74, respectively).
Focal bilateral CA3 atrophy
Mean subﬁeld volumes, corrected for differences in total
intracranial volume, are reported in Table 1. A three-way
mixed-model ANOVA was conducted on the subﬁeld vol-
umes, with two within-subjects variables (subﬁeld and side)
and one between-subjects variable (group). Mauchly’s test
demonstrated that the assumption of sphericity had been vio-
lated for side [2(9) = 81.61, P5 0.001] and subﬁeld by side
[2(9) = 82.44, P5 0.001], therefore, degrees of freedom
were corrected using Greenhouse-Geisser estimates (" = 0.46
and 0.49, respectively). There were signiﬁcant main effects of
group [F(1,34) = 6.08, P = 0.019], side [F(1,34) = 44.81,
P50.0001], and subﬁeld [F(1.84,62.49) = 346.80,
P50.0001]. Signiﬁcant two-way interactions were observed
between group and subﬁeld [F(1.84) = 4.21, P = 0.022]
and between side and subﬁeld [F(1.96,66.75) = 20.19,
P50.0001]. The three-way interaction between group,
subﬁeld, and side was not signiﬁcant [F(1.96) = 1.89,
P = 0.16].
Planned comparisons revealed a signiﬁcant reduction in
total CA3 volume–collapsed across left and right CA3 due
to the absence of a signiﬁcant three-way interaction–in the
patients relative to controls [F(1,34) = 16.87, P5 0.0001;
mean reduction = 28%, Cohen’s d = 1.37] (Fig. 2A),
whereas the differences in subiculum, CA1, CA2, and den-
tate gyrus volumes were not statistically signiﬁcant at the
alpha corrected for multiple comparisons (Cohen’s d
all5 0.8). Importantly, the pattern of results were un-
changed when these data were reanalysed with 17/18 pa-
tients who were LGI1 antibody-positive (Supplementary
material).
Retrospective assessment of neuroradiological reports
on the clinical MRI scans acquired at presentation
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revealed medial temporal lobe MRI signal hyperintensities
in ﬁve of the 18 patients. Even though hyperintense medial
temporal lobe signal progresses to hippocampal atrophy
as the signal declines (Chan et al., 2007; Bien et al., 2012),
hyperintensity on presentation was not a necessary
condition for chronic hippocampal subﬁeld atrophy and
did not affect the CA3 atrophy (Supplementary material).
In addition, antibody titre at presentation, listed in
Supplementary Table 1, did not predict the magnitude of
CA3 atrophy (1 = 0.002, R
2 = 0.07, t = 1.07, P = 0.30).
Likewise, CA3 atrophy was not predicted by median dis-
ease duration at 7.0 T MRI assessment (1 = 1.18,
R2 = 0.04, t = 0.84, P = 0.42; median = 4 years; range:
1–9 years).
Figure 1 7.0 T field strength T1-weighted whole-brain and 3D fast-spin echo whole-hippocampal MRIs obtained from LGI1
VGKC-complex antibody-mediated limbic encephalitis (VGKC-complex-Ab LE) group and age-matched control group.
(A) T1-weighted (0.6  0.6  0.6 mm3 resolution) coronal images from three patients in the LGI1 VGKC-complex antibody-mediated limbic
encephalitis group (i–iii) illustrating significant in vivo hippocampal atrophy. Normalized grey matter from controls and the patients with hippo-
campal damage derived from whole-brain voxel-based morphometry analysis were contrasted using a two sample t-test and thresholded at
P5 0.05 family-wise error corrected for multiple comparisons with SPM12. This whole-brain analysis revealed no significant differences between
the grey matter volumes of patients and controls (see ‘Results’ section and Supplementary material). (B) Native coronal images from whole-
hippocampal ultra-high resolution (0.39  0.39  1.0 mm3 resolution) 3D fast-spin echo sequence. Manual hippocampal subfield (subiculum,
CA1–3, dentate gyrus) segmentation was conducted along the full longitudinal axis and revealed selective lesions to bilateral CA3. Examples from
applying the manual hippocampal subfield segmentation protocol at 7.0 T in a control (1) and in a patient with LGI1 VGKC-complex antibody-
mediated limbic encephalitis (2). Each of the white lines (D–I) on the sagittal view of the hippocampus corresponds to six example coronal
locations along the anterior–posterior axis. H1’ and H2’ illustrate the segmentation protocol used in this study. The colour key corresponding to
the SUB (subiculum), CA1, CA2, CA3, DG (dentate gyrus) hippocampal subfields is shown below the image.
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Early and later intervention were both associated
with CA3 subfield atrophy
Patients were dichotomized into early and later intervention
groups with 3-month cut-off (Finke et al., 2012) (see
Supplementary material for ﬁrst-line treatment). An inde-
pendent-samples median test between patients receiving
early intervention (i.e.53 months from symptom-onset),
and later intervention (i.e. 43 months), and controls re-
vealed a signiﬁcant between-group difference in CA3
subﬁeld volume [2(2) = 8.13, P = 0.017]. Pairwise com-
parisons revealed that both intervention groups were asso-
ciated with signiﬁcant CA3 volume loss compared to
controls (early: z = 4.89, P = 0.027, Cohen’s d = 1.21;
later: z = 8.13, P = 0.004, Cohen’s d = 1.40).
Group voxel-by-voxel based morphometry
A voxel-by-voxel contrast of normalized grey matter con-
ducted using a two-sample t-test thresholded at P50.05
Figure 2 CA3 atrophy and impairment of autobiographical episodic memory in the LGI1 VGKC-complex antibody-mediated
limbic encephalitis group. (A) Results from hippocampal subfield segmentation in the LGI1 VGKC-complex antibody-mediated limbic en-
cephalitis patient group. Total intracranial volume-normalized total CA3 subfield volume reductions relative to the control group mean. Significant
CA3 atrophy was seen in the LGI1 VGKC-complex antibody-mediated limbic encephalitis group relative to age-matched control group [mean
reduction = 28%; F(1,34) = 16.87, P5 0.0001; Cohen’s d = 1.37]. Hippocampal subfield segmentation was based on 3D fast-spin echo images
acquired at 390 mm2 in-plane spatial resolution. Mean total intracranial volume-normalized total CA3 subfield volumes are reported in Table 1.
The error bar corresponds to the standard deviation; and (B) behavioural measure of postmorbid autobiographical episodic and semantic
memory. Cumulative (summed across the general and specific probes) mean number of internal (episodic) and external (non-episodic, mainly
personal semantic) details generated on the autobiographical interview, as a function of group. Recollected events correspond to memories
formed postmorbidly. Patients exhibited a significant deficit in the recollection of episodic details relative to controls *[F(1,30) = 14.94, P = 0.001,
Cohen’s d = 1.37], whereas the recollection of semantic details from the same autobiographical event in the patients was comparable to the
control group [F(1,30) = 0.71, P = 0.41, Cohen’s d = 0.30]. Error bars correspond to the SEM.
Table 1 Hippocampal subfield volumes in the LGI1 VGKC-complex antibody-mediated limbic encephalitis patient
group (n = 17 LGI1 positive and one patient who was LG1I and CASPR2 negative but VGKC-complex antibody-
positive) and control (n = 18) group
Subfield Mean total subfield volumes






CA1 986 (73, 311) 1171 (38, 162) ns
CA2 171 (9, 40) 180 (10, 41) ns
CA3* 377 (19, 82) 525 (30,128) 28%
Dentate gyrus 615 (42,180) 659 (23,95) ns
Subiculum 520 (33,140) 603 (22,95) ns
Values are mean, mm3, (SEM, SD).
Volumes were normalized to the total intracranial volumes obtained from the voxel-based morphometry analyses. Volumes are collapsed across the left and right hippocampi because
there was no significant interaction term between group, side (left, right), and subfield.
*Significant at the alpha criterion based on Bonferroni-Holm correction for multiple comparisons, following mixed-model ANOVA; significant mean percentage reduction shown for
CA3; ns = non-significant at alpha criterion corrected for multiple comparisons. Total intracranial volume was derived by applying the sequence of unified segmentation, as
implemented in SPM12, to the whole-brain T1-weighted 7.0 T images that were also acquired from each participant.
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family-wise error corrected for multiple comparisons across
the whole-brain revealed no suprathreshold clusters of grey
matter volume loss in the patients relative to controls, and
no signiﬁcant suprathreshold clusters for the reverse be-
tween-group contrast (LGI1 VGKC-complex antibody-
mediated limbic encephalitis4 controls). This result aligns
with other recent studies that have conducted comparable
voxel-based morphometry analyses (Wagner et al., 2015;
Finke et al., 2017).
Behaviour
Postmorbid autobiographical memory and neurop-
sychological profile
Results from the autobiographical interview revealed signiﬁ-
cant main effects of group (patients, controls)
[F(1,30) = 11.59, P = 0.002] and memory detail type (internal,
external) [F(1,30) = 123.24, P5 0.0001], and a signiﬁcant
interaction effect [F(1,30) = 18.07, P5 0.0001]. Planned com-
parisons indicated a selective and severe (mean reduc-
tion = 48.9%) loss of internal (episodic) [F(1,30) = 14.94,
P = 0.001, Cohen’s d = 1.37] but no loss of external (semantic)
[F(1,30) = 0.71, P = 0.41, Cohen’s d = 0.30] autobiographical
memory detail in the patients compared to the controls (Fig.
2B and Supplementary material). By contrast, the patients
were unimpaired on the indices of intelligence, executive func-
tion, attention, language, visuomotor, and visuoconstructive
skills (Table 2), and thus the loss in autobiographical episodic
memory is unlikely to be secondary to deﬁcits in cognitive
faculties that are strongly linked with memory performance
such as attention or executive function.
Notably, the variability in total CA3 volume of patients
and controls, i.e. with CA3 volume as a continuous inde-
pendent variable, selectively predicted the amount of in-
ternal (episodic) detail retrieved [t = 2.43, P = 0.021,
R2 = 0.17, 1 = 0.07], but not the external (semantic)
detail score [t = 0.92, P = 0.363, R2 = 0.03, 1 = 0.004].
Discussion
Ultra-high resolution anatomical magnetic resonance neuroi-
maging conducted at 7.0T and quantitative hippocampal
subﬁeld morphometry in chronic LGI1 VGKC-complex anti-
body-mediated limbic encephalitis revealed a restricted sub-
ﬁeld lesion proﬁle limited to the CA3. The results redeﬁne
the in vivo characterization of chronic LGI1 VGKC-complex
antibody-mediated limbic encephalitis in four areas: (i) hip-
pocampal atrophy was selective, affecting bilateral CA3, and
occurred in the absence of signiﬁcant grey matter loss in
brain regions outside of the hippocampus; (ii) CA3 atrophy
was evident following early and later intervention; (iii) CA3
atrophy was evident in patients with and without hyperin-
tense signal on presentation; and (iv) focal CA3 atrophy was
associated with severe impairment of postmorbid episodic
but not semantic autobiographical memory. The patients
were otherwise intact on the indices of verbal, visual, and
recognition memory. The dissociation between these indices
based on standardized tests of memory and the measure of
autobiographical episodic memory is consistent with the hy-
pothesis that retrieving autobiographical event knowledge is
qualitatively different from other forms of episodic retrieval
(Roediger and McDermott, 2013).
The results demonstrate the utility of conducting MRI
studies of medial temporal lobe pathology at submillimetre
spatial resolution. First, it enabled the detection of speciﬁc
subﬁeld pathology, and, second, it allowed comparison of
neuroradiological evidence in humans with autoantibody
binding patterns in rodents, which have been described as
part of the pathophysiological cascade that involves VGKC-
complex expression in the hippocampus (Vincent et al.,
2011). Unlike CA3, the between-group CA1 contrast did
not reach statistical signiﬁcance when corrected for multiple
comparisons. The selectivity aligns with evidence of greater
neuronal loss in CA3 than CA1 following seizures in homo-
zygous LGI1 knockout mice (Chabrol et al., 2010). CA3
volume loss may have arisen due to the particular vulner-
ability of CA3 versus CA1 to excitotoxic lesions associated
with seizures, given that IgG containing LGI1 antibodies
induce population epileptiform discharges in CA3 pyramidal
neurons in vitro (Lalic et al., 2011), or from complement-
mediated ﬁxation of bound antibodies (Bien et al., 2012).
Potential pathomechanisms related to human LGI1 anti-
bodies from rodent models involve interference with the
LGI1–ADAM22 interaction and reduced postsynaptic
AMPARs in vitro (Ohkawa et al., 2013). Furthermore,
even though anatomical localization of LGI1 gene tran-
scripts indicates enrichment in CA3 of the adult human
brain (Hawrylycz et al., 2012), which aligns with the expres-
sion of LGI1 gene transcripts in mouse dentate gyrus and
CA3 (Herranz-Perez et al., 2010), the pathogenic role and
antigenic targets of LGI1 autoantibodies need to be deter-
mined in humans. To date, evaluations have centred on as-
sociations between antibody levels and clinical features, the
detection of these antibodies in CSF as well as serum, and
the use of in vivo and in vitro experimental animal models
to develop similar changes to those seen in the human dis-
ease. Future studies will need to contrast evidence from lon-
gitudinal in vivo ultra-high resolution MRI with results from
ex vivo MRI acquisition to bridge the gap with nascent
immunohistological data that have identiﬁed CA4/dentate
gyrus with volume loss (Bauer and Bien, 2016).
Patients in the early and later intervention subgroups both
received high-dose corticosteroids as ﬁrst-line treatment. At
present, there is no standard treatment for autoimmune en-
cephalitis, but rapid immunotherapy with high-dose cortico-
steroids, intravenous immunoglobulin or plasma exchange
remain equivocal ﬁrst-line therapies (Irani et al., 2013).
Larger and preferably comparable numbers of patients in
each subgroup will need to be investigated to assess more
fully the impact of early intervention. Furthermore, the null
effect of the timing of treatment intervention on CA3 atrophy
and prior evidence that hyperintense medial temporal lobe
signal progresses to hippocampal atrophy as the signal
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declines may reﬂect the involvement of other mechanisms,
such as an initial, T cell-mediated inﬂammatory responses
that enable speciﬁc antibodies to enter the CNS and initiate
irreversible tissue damage in CA3.
The link between focal CA3 atrophy and impaired auto-
graphical episodic memory elaborates on the chronic
behavioural phenotype of VGKC-complex antibody-
mediated limbic encephalitis to include amnestic pathology
beyond reports of impaired verbal and ﬁgural memory
(Frisch et al., 2013; Bettcher et al., 2014; Butler et al.,
2014; Malter et al., 2014). Critically, prior reports did
not focus on speciﬁc mnemonic operations that are reliant
upon CA3 integrity. CA3 is an area involved in episodic-
like recall and mental imagery (Bonnici et al., 2013). CA3
is also associated with the capacity to reconstruct and recall
distinctive, precise details of newly acquired episodic mem-
ories (Chadwick et al., 2014), and these operations can be
assessed with extended assays of autobiographical episodic
memory such as the autobiographical interview (Levine et
al., 2002; Addis et al., 2007). The loss of internal detail on
the autobiographical interview likely reﬂected a loss of such
CA3-mediated features of episodic memory, and is compat-
ible with evidence that focal lesions involving human CA1
or the dentate gyrus (Bartsch et al., 2011; Baker et al.,
2016), the other two subﬁelds of hippocampal trisynaptic
circuit that subtends episodic memory, are sufﬁcient to
induce severe episodic amnesia. Future studies will need
to address the impact of the observed focal atrophy on
other CA3-mediated reconstructive, computational, and
episodic mechanisms alongside work identifying the speciﬁc
pathomechanisms in humans, because these data will be
key to developing optimized approaches to prevention, de-
tection, intervention, and clinical management.
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Table 2 Neuropsychological domain performance of the patients in the LGI1 VGKC-complex-Ab LE patient group
(n = 17 LGI1 antibody positive and one patient who was LG1I and CASPR2 negative but VGKC-complex antibody
positive)
Neuropsychological n Average z-score SEM. t d.f. P-value
Intelligence 16 0.90 0.20 4.46 15 50.001*
Verbal memory 17 0.34 0.20 1.70 16 ns
Visual memory 17 0.17 0.16 1.06 16 ns
Recognition memory 17 0.07 0.19 0.37 16 ns
Attention 15 0.22 0.14 1.62 14 ns
Executive function 17 0.65 0.16 4.13 16 0.001*
Language 17 0.51 0.22 2.35 16 0.032*
Visuomotor skills 17 0.17 0.10 1.80 16 ns
Visuoconstructive skills 17 0.01 0.32 0.03 16 ns
Domain scores are based on neuropsychological subtests that are described in the Supplementary material. Notably, delayed verbal recall performance (which contributed to the
verbal memory domain) was significantly different from normative data [n = 17, average z-score = 0.68, SEM = 0.24, t(16)=  2.83, P = 0.012].
*Patient group statistically different from normative data, P5 0.05, two-tailed; n = number of patients tested. Delayed verbal recall was comprised of Logical Memory II, Logical
Memory II themes and Word Lists II (WMS-III) and People Recall Test.
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